Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration
The Journal of Dermatology · 2026
DOI: 10.1111/1346-8138.70039 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Dermatology, 2026. Verfasst von Emi Yamazaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Colitis, Immune Checkpoint Inhibitors, Infliximab. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs) have improved melanoma outcomes but can cause severe immune‐related colitis. Infliximab is often used for steroid‐refractory cases, yet its effect on tumor control remains uncertain. We describe three advanced melanoma patients who developed grade 3–4 colitis after nivolumab plus ipilimumab and were treated with infliximab. Although gastrointestinal symptoms improved, all showed rapid disease progression and died within 3–9 months. These cases suggest that infliximab may compromise antitumor immunity in melanoma patients receiving ICIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
ORCID-Profile: Emi Yamazaki, Taku Fujimura, Yumi Kambayashi, Manami Takahashi-Watanabe, Kenta Oka, Yusuke Muto, Yoshihide Asano
Zitieren
APA
Yamazaki, E., Fujimura, T., Kambayashi, Y., Takahashi-Watanabe, M., Oka, K., Tamabuchi, E., Muto, Y., Hashimoto, A., & Asano, Y. (2026). Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70039
Vancouver
Yamazaki E, Fujimura T, Kambayashi Y, Takahashi-Watanabe M, Oka K, Tamabuchi E, et al. Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70039
BibTeX
@article{Yamazaki2026,
author = {Yamazaki, Emi and Fujimura, Taku and Kambayashi, Yumi and Takahashi-Watanabe, Manami and Oka, Kenta and Tamabuchi, Erika and Muto, Yusuke and Hashimoto, Akira and Asano, Yoshihide},
title = {Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration},
journal = {The Journal of Dermatology},
year = {2026},
doi = {10.1111/1346-8138.70039}
}
EUVIMED